SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-057122
Filing Date
2019-11-19
Accepted
2019-11-19 16:08:43
Documents
2
Period of Report
2019-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1605
2 EX-24 DOCUMENT attachment1.htm EX-24 3541
  Complete submission text file 0001209191-19-057122.txt   6684
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Issuer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONATUS PHARMACEUTICALS INC. 16745 WEST BERNARDO DRIVE, SUITE 200 SAN DIEGO CA 92127
Business Address
Scott Kathleen D. (Reporting) CIK: 0001794284 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36003 | Film No.: 191231229